A cluster randomized controlled trial on a procedure to ensure appropriate management of medications with strong teratogenicity.
Not Applicable
- Conditions
- Multiple myeloma
- Registration Number
- JPRN-UMIN000042166
- Lead Sponsor
- Ministry of Health, Labou Safety Measures Section
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
Not provided
Exclusion Criteria
Female patients with no possibility of pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Confirmation that all subjects and their partners do not report pregnancy Percentage of correct answers (correct answers to all questions of questionnaire 7 questions) of the understanding questionnaire (Appendix) at 24 weeks
- Secondary Outcome Measures
Name Time Method